Picture of Mycelx Technologies logo

MYX Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapNeutral

REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Saudi Arabia Business Operation Sale Completion

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240304:nRSD3641Fa&default-theme=true

RNS Number : 3641F  MyCelx Technologies Corporation  04 March 2024

4 March 2024

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

Saudi Arabia Business Operation Sale Completion

 

Further to the announcement on 22 February 2024, MYCELX Technologies
Corporation ("MYCELX" or the "Company"), the clean water and clean air
technology company transforming the environmental impact of industry, reports
that all conditions of the sale of the Company's Saudi Arabia Business to
Twarid Water Treatment LLC ("Twarid"), which is owned by Magellan SPV Water
Holdings Limited, have been satisfied and consequently the transaction has
completed and the Company has received the Initial Consideration. Proceeds
from the sale will strengthen the Company's balance sheet and provide the
runway it needs to accelerate growth in its core markets while continuing its
sales of MYCELX media products through the distributorship in Saudi Arabia.

 

The awareness and regulation of PFAS continues to grow in the US. The Company
expects the paid pilot trials completed in H1 will convert to contracts in H2
of this year. In the EOR market, two pilots will be operating in H1 along with
active proposals with several EOR producers that could convert by year end
with potential revenue impact in 2024 and 2025 depending on delivery.

 

Connie Mixon, CEO, commented:

 

"I am happy to announce the completion of the sale of MYCELX's Saudi Arabia
operations to Twarid. The Company can now focus on the large and lucrative
PFAS and EOR markets with the ability to strategically use working capital to
secure contracts. Both markets are very active and we intend to maintain focus
on the opportunities before us that require our differentiated technology and
will deliver long term value for all our stakeholders."

 

 

For further information, please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                  Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity Limited (Nomad and Sole Broker)

 Henry Fitzgerald-O'Connor                          Tel: +44 20 7523 8000

 Ana Ercegovic

 Celicourt Communications (Financial PR)

 Mark Antelme                                       Tel: +44 20 7770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDQXLFBZXLFBBE

Recent news on Mycelx Technologies

See all news